This inventor holds 42 USPTO granted patents and 2 published patent applications and 8 EPO patents, primarily in Hepatitis Virus Detection. Top assignees: Innogenetics N.v., N.v. Innogenetics S.a., Innogenetics, S.a.. Active years: 1998-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- St. Kruis Brugge, BE (2003 - 2005)
- Brugge, BE (1998 - 2007)
- Bruges, BE (1999 - 2014)
Company Filing History:
25 out of 82 
9 out of 43 
3 out of 4 Years Active: 1998-2014
Areas of Expertise:
Title: Geert Maertens: A Pioneer in HBV Detection Technologies
Introduction: Geert Maertens, an accomplished inventor based in Bruges, Belgium, has made significant contributions to the field of medical diagnostics with a focus on hepatitis B virus (HBV). With a remarkable portfolio of 42 patents, Maertens has been at the forefront of innovation in genetic analysis and detection methods.
Latest Patents: Among Maertens' latest inventions is a sophisticated method for typing and detecting HBV in biological samples. This patented methodology involves the hybridization of polynucleic acids with a combination of nucleotide probes that specifically target various mutant sequences within the HBV genome. The technique is designed to enhance the detection and genetic analysis of HBV, aiding in the identification of its genotypes and mutants. The invention also includes sets of nucleotide probes and assay kits that support these advanced methods, making it a pivotal advancement in HBV research and diagnostics.
Career Highlights: Throughout his career, Geert Maertens has been associated with notable companies in the biotechnology sector such as Innogenetics NV and N.V. Innogenetics S.A. His work has been instrumental in developing cutting-edge technologies that address critical challenges in the field of virology.
Collaborations: In his pursuit of innovation, Maertens has collaborated with esteemed colleagues like Lieven Jozef Stuyver and Rudi Rossau. These collaborations have provided valuable insights and fostered a productive environment for developing advanced diagnostic methods.
Conclusion: Geert Maertens stands out as a significant figure in the ongoing battle against HBV through his innovative inventions and collaborative spirit. With his extensive patent portfolio, he continues to impact the medical research landscape, helping to advance the understanding and detection of viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile